Mersana Therapeutics Inc (MRSN) — Free Cash Flow Generation Index

Latest as of September 2022: 0.99x

Mersana Therapeutics Inc (MRSN) has a Free Cash Flow Generation Index of 0.99x as of September 2022. Free cash flow of $54.17 Million represents 1% of operating cash flow ($54.60 Million). Explore Mersana Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.99x
Free Cash Flow / Operating CF

Free Cash Flow

$54.17 Million
USD

Operating Cash Flow

$54.60 Million
USD

Capital Expenditures

$426.00K
USD

Mersana Therapeutics Inc Free Cash Flow Generation Index (2016–2016)

Historical FCF Generation Index trend for Mersana Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Mersana Therapeutics Inc cash conversion from operations.

Annual Free Cash Flow Generation for Mersana Therapeutics Inc (2016–2016)

Year-by-year Free Cash Flow Generation Index for Mersana Therapeutics Inc. Check Mersana Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2016 0.97x $30.50 Million $31.59 Million $1.08 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).